This study tests a new drug called Ir-CPI in people who have had a brain bleed (intracerebral hemorrhage). The goal is to see if the drug is safe and can reduce further brain injury when added to standard care. About 23 adults with a first-time brain bleed are taking part. The st…
Phase: PHASE2 • Sponsor: Bioxodes S.A. • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC